Revvity | PKI - 贸易债权人



金融业
股票价格
USD
资产
USD 12B
现金及等价物
USD 860.32M
销售成本
USD 323.46M
流动资产
USD 2.13B
流动负债
USD 1.24B
债务
USD 3.4B
股息收益率
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
员工
11K
EPS每股收益
USD 1.06
股本和储备
USD 7.25B
销售毛利
USD 387.66M
债务利息支出
USD 24.72M
利息收入
USD 5.75M
贷款资金
USD 2.63B
市值
USD 13.61B
净收入
USD 40.72M
营业费用
USD 628.35M
营业利润
USD 82.77M
普通股股本
USD 111.8M
PE价格收益
30.79
税前利润
USD 91.56M
销售收入
USD 711M
销售和管理费用
USD 253.88M
股票
USD 387.51M
贸易债权人
USD 169.68M
应收帐款人
USD 691.38M


贸易债权人 更改 日
Agilent USD 615M 13M 2026-03
Align Technology USD 123.72M 2.27M 2026-03
Bio Techne USD 95.6M 3.97M 2026-03
Bio-Rad Laboratories USD 133.1M 4.1M 2026-03
Bruker USD 269.1M 53.2M 2026-03
Celltrion KRW 88.58B 9.9B 2026-03
Charles River Laboratories USD 133.95M 14.85M 2026-03
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Danaher USD 2.07B 282M 2026-06
Dentsply International USD 259M 41M 2026-03
Deva Holding AS TRY 809.81M 105.88M 2023-09
Dianthus Therapeutics USD 5.27M 4.45M 2026-03
Divis Laboratories Ltd INR 12.11B 1.71B 2026-03
Edwards Lifesciences USD 181.1M 46.4M 2026-03
Illumina USD 218M 22M 2026-03
Intuitive Surgical USD 1.92B 66.6M 2026-06
IQVIA Holdings USD 3.64B 112M 2026-03
Kangmei Pharma CNY 2.46B 153.5M 2026-03
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Laboratory Of America USD 695.7M 145.1M 2026-03
Malin Corporation EUR 700K 200K 2024-12
Medical Developments International AUD 4.31M 2.18M 2025-12
Mesa Laboratories USD 5.25M 163K 2025-12
Mettler Toledo International USD 228.72M 37.91M 2026-03
Myriad Genetics USD 32.6M 2.6M 2026-03
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
OraSure Technologies USD 10.63M 4.11M 2026-03
Organigram Holdings CAD 73.14M 2.06M 2026-03
Ovoca Bio EUR 186K 23K 2025-06
Pacific Biosciences Of California USD 13.61M 7.16M 2026-03
Pharma Mar EUR 43.83M 10.51M 2026-03
Qiagen NV USD 72.66M 2.11M 2025-12
Quest Diagnostics USD 1.5B 100M 2026-03
Quidel USD 243.5M 35.9M 2026-03
Repligen USD 34.66M 4.65M 2026-03
Revvity USD 169.68M 15.78M 2026-03
Sartorius EUR 345.3M 2.2M 2026-03
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
Thermo Fisher Scientific USD 3.34B 278M 2026-03
Tilray USD 114.5M 3.69M 2025-09
Waters USD 103.78M 11.95M 2025-12
Zealand Pharma A/S 346.6M 102.71M 2025-12
Zz Pientze Pharmaceu CNY 457.05M 59.09M 2026-03